Novo Nordisk A/S Increased Operating Profit In Local Currencies By 15% In 2013

Published: Jan 30, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGSVAERD, Denmark, Jan. 30, 2014 (GLOBE NEWSWIRE) -- Sales growth of 12% in local currencies driven by growth in sales of Victoza®, NovoRapid® and Levemir®

Sales increased by 12% in local currencies and by 7% to 83.6 billion in Danish kroner.

Help employers find you! Check out all the jobs and post your resume.

Back to news